Total (N = 25) | Frequency (%) |
---|---|
Age (years) | |
 Mean ± SD (median) | 42.88 ± 10.28 (43.00) |
 Min–max | 15.00–55.00 |
Gender | |
 Male | 10 (40.00%) |
 Female | 15 (60.00%) |
Number of lesions (NoL) | |
 1 | 17 (68.00%) |
 2 | 2 (8.00%) |
 3 | 4 (16.00%) |
 4 | 1 (4.00%) |
 9 | 1 (4.00%) |
Lesion size (mm) | |
 Mean ± SD (median) | 7.12 ± 2.79 (5.95) |
 Min–max | 1.10–15.00 |
Localization of lesions | |
 Right lobe (NoL) | 18 (28, 60.87%) |
 Left lobe (NoL) | 8 (12, 26.09%) |
 Porta hepatis (NoL) | 2 (2, 4.35%) |
 Junction of left and right lobes (NoL) | 3 (3, 6.52%) |
 Post-mediastinum (NoL) | 1 (1, 2.17%) |
Number of CE lesions | |
 CE1 (NoL) | 3 (5, 20.83%) |
 CE2 (NoL) | 2 (3, 12.50%) |
 CE3a (NoL) | 1 (1, 4.17%) |
CE3b (NoL) | 1 (1, 4.16%) |
 CE4 (NoL) | 3 (10, 41.67%) |
 CE5 (NoL) | 4 (4, 16.67%) |
 Total (NoL) | 9 (24, 100.00%) |
Number of AE lesions | |
 Hailstorm sign (NoL) | 4 (5, 22.72%) |
 Pseudocystic sign (NoL) | 6 (6, 27.27%) |
 Hemangioma-like sign (NoL) | 7 (9, 40.91%) |
 Ossification sign (NoL) | 1 (1, 4.55%) |
 Metastasis-like sign (NoL) | 1 (1, 4.55%) |
 Total (NoL) | 16 (22, 100.00%) |